The settlement ends two lawsuits that claimed that some of the products were “deceptively marketed, advertised, labeled, and sold as `Non-Drowsy,’” but actually contained dextromethorphan, which may ...

The deadline to get money back as part of a $4.5 million class action settlement involving certain Robitussin products is here. Consumers have until May 12, 2025 to sign up to be included in the ...

Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.

At first glance, New Yorkers may think that’s an old photo above, since the two men are holding MetroCards, the subway pass that went extinct with the coming of the new year. But participants in the ...

Robitussin owes some cold sufferers money as part of a class-action settlement. The cough medicine brand has agreed to pay $4.5 million to resolve claims that it duped consumers by marketing its ...